Lasky F D, Ahuja K K, Karmen A
Clin Chem. 1977 Aug;23(8):1444-8.
We studied the EMIT (Enzyme Multiplied Immunoassay Technique, Syva) procedures for the assay of phenytoin and phenobarbital in serum, adapting them to the miniature Centrifugal Fast Analyzer. For different concentrations of drug, each rate of reaction decreased continuously with time, tending to converge on a single common value. The rate was most affected by the concentration of drug almost immediately after the reagents were mixed, less so thereafter. The antibody evidently is present in sufficient excess to bind all the enzyme-labeled drug ordinarily present, but the antibody-bound enzyme was only 75% inhibited; this helps explain the appreciable residual activity when no drug is present. The reaction course was the same whether the serum and enzyme-labeled drug were added to the antibody sequentially or simultaneously, which suggests that antibody is bound to drug appreciably faster than to enzyme-labeled drug. The reaction rates 15 to 30 s after mixing were used as the measure of the drug concentrations. These results were confirmed by noting the rates at successive 15-s intervals. The analyzer yielded a run-to-run CV of 10% for phenobarbital at 30 mg/liter, and 9% for phenytoin at 15 mg/liter, as compared to the 15% quoted by Syva.
我们研究了采用酶倍增免疫分析技术(EMIT,Syva公司)检测血清中苯妥英和苯巴比妥的方法,并将其应用于微型离心快速分析仪。对于不同浓度的药物,每种反应速率均随时间持续下降,最终趋于一个共同值。在试剂混合后几乎立即,反应速率受药物浓度的影响最大,之后影响则较小。显然,抗体过量存在,足以结合通常存在的所有酶标记药物,但抗体结合的酶仅受到75%的抑制;这有助于解释在无药物存在时仍有相当可观的残余活性。无论血清和酶标记药物是依次还是同时加入抗体,反应过程都是相同的,这表明抗体与药物的结合明显快于与酶标记药物的结合。混合后15至30秒的反应速率用作药物浓度的测量指标。通过记录连续15秒间隔的速率,这些结果得到了证实。与Syva公司引用的15%相比,该分析仪对30毫克/升苯巴比妥的批间变异系数为10%,对15毫克/升苯妥英的批间变异系数为9%。